BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

213 related articles for article (PubMed ID: 23338823)

  • 1. Effects of TRAIL and taurolidine on apoptosis and proliferation in human rhabdomyosarcoma, leiomyosarcoma and epithelioid cell sarcoma.
    Karlisch C; Harati K; Chromik AM; Bulut D; Klein-Hitpass L; Goertz O; Hirsch T; Lehnhardt M; Uhl W; Daigeler A
    Int J Oncol; 2013 Mar; 42(3):945-56. PubMed ID: 23338823
    [TBL] [Abstract][Full Text] [Related]  

  • 2. TRAIL and Taurolidine induce apoptosis and decrease proliferation in human fibrosarcoma.
    Daigeler A; Brenzel C; Bulut D; Geisler A; Hilgert C; Lehnhardt M; Steinau HU; Flier A; Steinstraesser L; Klein-Hitpass L; Mittelkötter U; Uhl W; Chromik AM
    J Exp Clin Cancer Res; 2008 Dec; 27(1):82. PubMed ID: 19077262
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic apoptotic effects of taurolidine and TRAIL on squamous carcinoma cells of the esophagus.
    Daigeler A; Chromik AM; Geisler A; Bulut D; Hilgert C; Krieg A; Klein-Hitpass L; Lehnhardt M; Uhl W; Mittelkötter U
    Int J Oncol; 2008 Jun; 32(6):1205-20. PubMed ID: 18497982
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synergistic effects in apoptosis induction by taurolidine and TRAIL in HCT-15 colon carcinoma cells.
    Chromik AM; Daigeler A; Hilgert C; Bulut D; Geisler A; Liu V; Otte JM; Uhl W; Mittelkötter U
    J Invest Surg; 2007; 20(6):339-48. PubMed ID: 18097875
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Synergistic effects of sonoporation and taurolidin/TRAIL on apoptosis in human fibrosarcoma.
    Daigeler A; Chromik AM; Haendschke K; Emmelmann S; Siepmann M; Hensel K; Schmitz G; Klein-Hitpass L; Steinau HU; Lehnhardt M; Hauser J
    Ultrasound Med Biol; 2010 Nov; 36(11):1893-906. PubMed ID: 20870344
    [TBL] [Abstract][Full Text] [Related]  

  • 6. TRAIL and taurolidine enhance the anticancer activity of doxorubicin, trabectedin and mafosfamide in HT1080 human fibrosarcoma cells.
    Harati K; Chromik AM; Bulut D; Goertz O; Hahn S; Hirsch T; Klein-Hitpass L; Lehnhardt M; Uhl W; Daigeler A
    Anticancer Res; 2012 Jul; 32(7):2967-84. PubMed ID: 22753761
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemotherapeutic agents sensitize sarcoma cell lines to tumor necrosis factor-related apoptosis-inducing ligand-induced caspase-8 activation, apoptosis and loss of mitochondrial membrane potential.
    Hotta T; Suzuki H; Nagai S; Yamamoto K; Imakiire A; Takada E; Itoh M; Mizuguchi J
    J Orthop Res; 2003 Sep; 21(5):949-57. PubMed ID: 12919886
    [TBL] [Abstract][Full Text] [Related]  

  • 8. C-jun N-terminal kinase activation is required for apoptotic cell death induced by TNF-related apoptosis-inducing ligand plus DNA-damaging agents in sarcoma cell lines.
    Mikami T; Koyama T; Koyama T; Imakiire A; Yamamoto K; Furuhata M; Toyota H; Mizuguchi J
    Anticancer Res; 2006; 26(2A):1153-60. PubMed ID: 16619517
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Influence of casein kinase II in tumor necrosis factor-related apoptosis-inducing ligand-induced apoptosis in human rhabdomyosarcoma cells.
    Izeradjene K; Douglas L; Delaney A; Houghton JA
    Clin Cancer Res; 2004 Oct; 10(19):6650-60. PubMed ID: 15475455
    [TBL] [Abstract][Full Text] [Related]  

  • 10. COX-2 inhibitors sensitize human hepatocellular carcinoma cells to TRAIL-induced apoptosis.
    Yamanaka Y; Shiraki K; Inoue T; Miyashita K; Fuke H; Yamaguchi Y; Yamamoto N; Ito K; Sugimoto K; Nakano T
    Int J Mol Med; 2006 Jul; 18(1):41-7. PubMed ID: 16786154
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Human melanoma cells selected for resistance to apoptosis by prolonged exposure to tumor necrosis factor-related apoptosis-inducing ligand are more vulnerable to necrotic cell death induced by cisplatin.
    Zhang XD; Wu JJ; Gillespie S; Borrow J; Hersey P
    Clin Cancer Res; 2006 Feb; 12(4):1355-64. PubMed ID: 16489094
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Bortezomib induces caspase-dependent apoptosis in Hodgkin lymphoma cell lines and is associated with reduced c-FLIP expression: a gene expression profiling study with implications for potential combination therapies.
    Zhao X; Qiu W; Kung J; Zhao X; Peng X; Yegappan M; Yen-Lieberman B; Hsi ED
    Leuk Res; 2008 Feb; 32(2):275-85. PubMed ID: 17659339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epidermal growth factor receptor blockade in combination with conventional chemotherapy inhibits soft tissue sarcoma cell growth in vitro and in vivo.
    Ren W; Korchin B; Zhu QS; Wei C; Dicker A; Heymach J; Lazar A; Pollock RE; Lev D
    Clin Cancer Res; 2008 May; 14(9):2785-95. PubMed ID: 18451246
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Imatinib enhances human melanoma cell susceptibility to TRAIL-induced cell death: Relationship to Bcl-2 family and caspase activation.
    Hamaï A; Richon C; Meslin F; Faure F; Kauffmann A; Lecluse Y; Jalil A; Larue L; Avril MF; Chouaib S; Mehrpour M
    Oncogene; 2006 Dec; 25(58):7618-34. PubMed ID: 16983347
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Histone deacetylase inhibitors strongly sensitise neuroblastoma cells to TRAIL-induced apoptosis by a caspases-dependent increase of the pro- to anti-apoptotic proteins ratio.
    Mühlethaler-Mottet A; Flahaut M; Bourloud KB; Auderset K; Meier R; Joseph JM; Gross N
    BMC Cancer; 2006 Aug; 6():214. PubMed ID: 16930472
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Gene expression analysis of cell death induction by taurolidine in different malignant cell lines.
    Chromik AM; Hahn SA; Daigeler A; Flier A; Bulut D; May C; Harati K; Roschinsky J; Sülberg D; Weyhe D; Mittelkötter U; Uhl W
    BMC Cancer; 2010 Oct; 10():595. PubMed ID: 21034493
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of taurolidine, a novel antineoplastic agent, on human malignant mesothelioma.
    Nici L; Monfils B; Calabresi P
    Clin Cancer Res; 2004 Nov; 10(22):7655-61. PubMed ID: 15569998
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction and regulation of tumor necrosis factor-related apoptosis-inducing ligand/Apo-2 ligand-mediated apoptosis in renal cell carcinoma.
    Griffith TS; Fialkov JM; Scott DL; Azuhata T; Williams RD; Wall NR; Altieri DC; Sandler AD
    Cancer Res; 2002 Jun; 62(11):3093-9. PubMed ID: 12036919
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Induction of apoptosis in osteogenic sarcoma cells by combination of tumor necrosis factor-related apoptosis inducing ligand and chemotherapeutic agents.
    Sun J; Fu ZM; Fang CQ; Li JH
    Chin Med J (Engl); 2007 Mar; 120(5):400-4. PubMed ID: 17376311
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trail-induced apoptosis and interaction with cytotoxic agents in soft tissue sarcoma cell lines.
    Tomek S; Koestler W; Horak P; Grunt T; Brodowicz T; Pribill I; Halaschek J; Haller G; Wiltschke C; Zielinski CC; Krainer M
    Eur J Cancer; 2003 Jun; 39(9):1318-29. PubMed ID: 12763223
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.